Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Pharmaceutical
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Strength
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Pack Size
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Form
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Source
European Medicines Agency
Safety Profile
Contraindications
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Side Effects
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Scan this QR code to access this page quickly on your mobile device.